category

News

Announcing Novascan’s Launch of a Human GI trial for its nsCanary™ Cancer Detection Device

Announcing Novascan’s Launch of a Human GI trial for its nsCanary™ Cancer Detection Device

NovaScan, a clinical stage oncology company based in Chicago, announced that it has started a human GI clinical trial for its nsCanary™ device at Texas International Endoscopy Center (TIEC), led by Principal Investigator Isaac Raijman MD. This trial will include 200 patients across several clinical areas, including upper and lower gastrointestinal lumen, pancreas and biliary tract. It is anticipated that the trial will collect the data by the Spring of 2023.

read more
The Arts of Healing Foundation

The Arts of Healing Foundation

EndoRx and DFC Medical were honored to be the primary underwriting sponsors for this diverse and dynamic group of women in a runway show like no other – a runway of role models.

read more
NovaScan Lung Studies Published in a Leading Peer Reviewed Journal

NovaScan Lung Studies Published in a Leading Peer Reviewed Journal

NovaScan, a clinical-stage oncology company based in Chicago and Milwaukee, recently had its publication titled “The Cole Relaxation Frequency as a Parameter to Identify Cancer in Lung Tissue: Preliminary Animal and ex vivo Patient Studies” accepted in the highly regarded peer-reviewed journal, JMIR Biomedical Engineering.

read more
NovaScan Completes $8MM Series B Financing

NovaScan Completes $8MM Series B Financing

NovaScan announced that it has completed a $8 Million Series B financing, led by Builders VC. As a part of this transaction, Amit Mehta, MD, a partner at Builders, will join the Board of Directors of NovaScan.

read more